Biotechnology Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder June 2, 2022
Biotechnology GBT to Host Investor Conference Call on Friday, June 10 and Participate in Upcoming Investor Conferences June 1, 2022